Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
Research We Fund: Extramural Discovery Science
-
-
- Discovery Boost Grants (DBG)
- Arizona (AZ) Discovery Boost Grants (DBG)
- AHEAD (Advancing Health Equity and Addressing Cancer Disparities) Awards
- Mission Boost Grants (MBG)
- Research Scholar Grants
- Postdoctoral Fellowships
- Clinician Scientist Development Grant (CSDG)
- ASTRO-ACS Clinician Scientist Development Grant (CSDG)
- Institutional Research Grants
- RFA: Extramural Discovery Science Accelerator Award
- HEALED Gold Medal RFA to Support Mind-Body-Spirit Wellness in Cancer Survivors
- RFA: Cancer Health Equity Research Centers
- RFA: Real-World Data Impact Award (RWIA)
- RFA: The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services
- ACS Professor Award
- Clinical Research Professor
- RFA: Metastasis in Melanoma and Other Cancers
- TheoryLab Collaborative (TLC) Grant
- Extramural Grants Department Staff Contacts
- Definition of Research Areas
- FAQs: ACS Extramural Discovery Science and Grant Application Submissions
- Extramural Priority Research Areas
-
-
- Peer Review Committee for Experimental Therapeutics (ET)
- Peer Review Committee for DNA Mechanisms in Cancer (DMC)
- Peer Review Committee for Institutional Research Grants (IRG)
- Peer Review Committee for RNA Mechanisms in Cancer (RMC)
- Peer Review Committee for Tumor Biochemistry and Endocrinology (TBE)
- Peer Review Committee for Cancer Cell Biology (CCB)
- Peer Review Committee for Cancer Detection and Progression (CDP)
- Peer Review Committee for Healthcare Outcomes, Policy, and Systems Research (HOPS)
- Peer Review Committee for Mission Boost Grants
- Peer Review Committee for Immunology and Blood Cell Development (IBCD)
- Peer Review Committee for Treatment, Palliative Care, and Survivorship Research
- Discovery Scientific Council
- Stakeholder Participation on Grant Peer Review Committees
- Peer Review Committee for Metastasis and Microenvironment (MM)
- Peer Review Committee for Etiology, Screening, and Early Detection (ESED)
- Peer Review Committee for Cancer Prevention and Health Promotion (CPHP)
- ACS Professor Peer Review Committee
- American Cancer Society Professors
Biochemistry and Immunology of Cancer
Scientific Director:
Doug Hurst, PhD
Scientist:
Nicole Lopanik, PhD
For all questions, contact:
Nicole.Lopanik@cancer.org
This program accepts grant applications that focus on:
- Genes involved in cancer and the roles alterations in those genes (mutations, deletions, and amplifications) play in cancer processes
- Molecules involved in cancer (proteins, nucleic acids, lipids, and carbohydrates) and how alterations in those molecules affect the disease
- Potential targets for new treatments of cancer and mechanisms of signal transduction
- Investigations of the immunology of cancer including blood cell development, immunotherapy, inflammatory responses, immunosurveillance, and innate and adaptive immunity
- Investigations of oncogenic viruses, microbial pathogens, or the microbiome, and their involvement with molecular processes and pathways within cancer cells including tumor antigens and immunity
Featured Term:
Germline Pathogenic Variations
A type of mutated gene that gets passed down from a parent to child and that causes disease, such as cancer. The BRCA1 and BRCA2 mutations are examples of germline pathogenic variations because they are passed down by parents and increase the risk of developing several types of cancer.